Literature DB >> 6932390

Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus.

N Tanigaki, R Tosi, D Pressman, G B Ferrara.   

Abstract

Human Ia(-like) specificities controlled by gene loci other than HLA-DR were searched for at the molecular level in cells of human B-cell-type cell lines which carry two established DR specificities. Chevalier cells of DRw3 and 7 and U698M cells of DRw2 and 4 were used. Their Ia molecules were partially purified, radioiodinated and analyzed for Ia specificities by the direct binding and sequential binding assays with a selected panel of human Ia alloantisera. It was possible in both the cell lines to define a third subset of Ia molecules carrying a new specificity in addition to two Ia subsets carrying the established DR specificities. The new specificity was detected by putative anti-DRw4 and anti-DRw7 antisera and was closely associated with DRw4 and DRw7 at population level. It was thus designated provisionally as BR4X7. These results suggest that the BR4X7 specificity is coded for by a separate Ia locus closely linked to HLA-DR locus. The determinant(s) responsible for BR4X7 was located on the small subunit of Ia molecules.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932390     DOI: 10.1007/bf01561564

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

1.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

2.  Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay.

Authors:  N Tanigaki; Y Miyakawa; Y Yagi; V P Kreiter; D Pressman
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Heavy HLA-DR (Ia) antigen chain is controlled by the MHC region.

Authors:  L Klareskog; L Rask; J Fohlman; P A Peterson
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

5.  Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules.

Authors:  K Nakamuro; N Tanigaki
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

6.  Structural polymorphism of human DR antigens.

Authors:  J Silver; S Ferrone
Journal:  Nature       Date:  1979-05-31       Impact factor: 49.962

7.  Structural studies on the murine Ia alloantigens. IV. NH2-terminal sequence analysis of allelic products of the I-A and I-E/C subregions.

Authors:  R G Cook; M H Siegelman; J D Capra; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

8.  Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules.

Authors:  K Nakamuro; N Tanigaki; D Pressman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

9.  Cellular distrubtion, purification, and molecular nature of human Ia antigens.

Authors:  D Snary; C J Barnstable; W F Bodmer; P N Goodfellow; M J Crumpton
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Two-gene control of the expression of a murine Ia antigen.

Authors:  P P Jones; D B Murphy; H O McDevitt
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  26 in total

1.  Serological discrimination of DR4 haplotypes by radioimmunoassay.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Analysis of the DR beta chains from two DRw6 cell lines (WT46 and WT52): recombination in vivo may have generated new haplotypes.

Authors:  P J Knudsen; J McLean; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.

Authors:  R Sorrentino; J Lillie; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits.

Authors:  V Quaranta; N Tanigaki; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.

Authors:  M L Markert; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.

Authors:  A Zeevi; C Scheffel; K Annen; G Bass; M Marrari; R J Duquesnoy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.

Authors:  D D Eckels; R J Hartzman
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Unusual distribution of Ia-like antigens on canine lymphocytes.

Authors:  H J Deeg; J C Wulff; S DeRose; G E Sale; M Braun; M A Brown; S C Springmeyer; P J Martin; R Storb
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.